This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the U.S. Department of Health and Human Services, to Illumina, Inc. for a MiSeq and NextSeq maintenance service agreement. The contract has a ceiling value of $54,252.56 and a performance period ending on March 24, 2030. Illumina is a manufacturer of genetic sequencing systems and related consumables. The award does not utilize any small business set-asides. Illumina has previously received other prime federal contract and subcontract awards from agencies such as the NIH, CDC, USDA, and VA to provide their sequencing instruments, reagents, and bioinformatics services in support of genomic research and diagnostics.
Generated 3/23/25, 12:53 AM